MYX.L

MyCelx Technologies Corporation (DI)
MyCelx Tech. Corp. - Director Dealings & Total Voting Rights
23rd August 2024, 10:05
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 6160B
MyCelx Technologies Corporation
23 August 2024
 

23 August 2024

 

MYCELX Technologies Corporation

("MYCELX" or the "Company") (AIM:MYX)

 

Director Dealings & Total Voting Rights

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company established to transform the environmental impact of industry, announces, further to the Placing and Subscription this morning, the following participation by Directors of the Company.

 

 

Director

Shares held prior to Admission

New Shares Purchased

Shares held post Admission

Percentage of Enlarged Issued Share Capital

Thomas Lamb

325,175

48,836

374,011

1.54%

Connie Mixon1

2,803,944

100,632

2,931,576

12.06%

Andre Schnabl

118,011

48,836

166,847

0.69%

 

1 Mrs. Mixon's shareholding includes 229,008 shares in the Company held by her spouse.

 

 

Total Voting Rights

In conformity with the FCA's Disclosure Guidance and Transparency Rules (the "Rules") provision 5.6.1, the Company would like to notify the market that following Admission on 4 September 2024 its issued share capital will consist of 24,315,271 Common Shares of US$0.025 each.

Shareholders should use 24,315,271 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

Terms and definitions used in this announcement shall have the same meaning as ascribed to them in the Proposed Placing and Subscription Announcement released at 7:00 a.m. on 23 August 2024, unless the context requires otherwise.

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity Limited (Nominated Adviser and Sole Broker)

Henry Fitzgerald-O'Connor

Charlie Hammond

 

 

Tel: +44 20 7523 8000

Celicourt Communications (Financial PR)

Mark Antelme

Jimmy Lea

Charlie Denley-Myerson

 

 

Tel: +44 20 7770 6424

 

Notifications of transactions of persons discharging managerial responsibility or connected persons

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

1.   Thomas Lamb

2.   Connie Mixon

3.   Andre Schnabl

2

 

Reason for the notification

a)

 

Position/status

 

1.   Non-Executive Chairman

2.   Chief Executive Officer

3.   Non-Executive Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Mycelx Technologies Corporation

b)

 

LEI

 

213800UJZINIK2VD1G48

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

Common shares of US$0.025


US62847T2024

b)

 

Nature of the transaction

Purchase of Common Shares

c)

 

Price(s) and volume(s)

Price(s)

 

Volume(s)

1.   51.5 pence

2.   51.5 pence

3.   51.5 pence

 

1.   48,836

2.   100,632

3.   48,836

d)

 

Aggregated information

- Aggregated volume

- Price

 

N/A

N/A

 

e)

 

Date of the transaction

 

23 August 2024

f)

 

Place of the transaction

London Stock Exchange

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZGZRGFZGDZM]]>
TwitterFacebookLinkedIn